Variant report

Variant	esv3393710
Chromosome Location	chr2:20211621-20213469
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr2:20211742-20211922	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr2:20212407-20212580	H1-hESC	embryonic stem cell:	n/a	n/a
3	CEBPB	chr2:20212541-20212819	HepG2	liver:	n/a	n/a
4	CEBPB	chr2:20212498-20212957	H1-hESC	embryonic stem cell:	n/a	n/a
5	CEBPB	chr2:20212497-20212772	Hela-S3	cervix:	n/a	n/a
6	CEBPB	chr2:20212535-20212750	IMR90	lung:	n/a	n/a
7	CEBPD	chr2:20212001-20212749	HepG2	liver:	n/a	n/a
8	CHD1	chr2:20212953-20213244	H1-hESC	embryonic stem cell:	n/a	n/a
9	CHD1	chr2:20212566-20212679	H1-hESC	embryonic stem cell:	n/a	chr2:20212609-20212619
10	CREB1	chr2:20212164-20212716	A549	lung:	n/a	n/a
11	CTBP2	chr2:20212493-20212832	H1-hESC	embryonic stem cell:	n/a	n/a
12	CTCF	chr2:20213320-20213470	GM06990	blood:	n/a	n/a
13	E2F4	chr2:20212896-20212898	MCF10A-Er-Src	breast:	n/a	n/a
14	E2F4	chr2:20212039-20212652	MCF10A-Er-Src	breast:	n/a	chr2:20212148-20212160
15	E2F6	chr2:20211884-20212355	H1-hESC	embryonic stem cell:	n/a	chr2:20212148-20212160
16	E2F6	chr2:20212309-20212771	A549	lung:	n/a	chr2:20212761-20212771
17	E2F6	chr2:20211866-20212879	A549	lung:	n/a	chr2:20212761-20212771 chr2:20212148-20212160
18	E2F6	chr2:20212338-20212574	K562	blood:	n/a	n/a
19	ELF1	chr2:20211999-20212586	HepG2	liver:	n/a	chr2:20212197-20212210
20	ELF1	chr2:20211909-20212367	MCF-7	breast:	n/a	chr2:20212197-20212210
21	ELF1	chr2:20212063-20212322	K562	blood:	n/a	chr2:20212197-20212210
22	ELF1	chr2:20211797-20212460	GM12878	blood:	n/a	chr2:20212197-20212210
23	ELF1	chr2:20212056-20212358	K562	blood:	n/a	chr2:20212197-20212210
24	ELF1	chr2:20212041-20212404	HepG2	liver:	n/a	chr2:20212197-20212210
25	ELF1	chr2:20212977-20213292	HepG2	liver:	n/a	n/a
26	EP300	chr2:20212452-20212566	HepG2	liver:	n/a	n/a
27	EP300	chr2:20212317-20213285	HepG2	liver:	n/a	chr2:20212923-20212937 chr2:20212921-20212935
28	EP300	chr2:20212720-20213265	HepG2	liver:	n/a	chr2:20212923-20212937 chr2:20212921-20212935
29	EP300	chr2:20212897-20213194	HepG2	liver:	n/a	chr2:20212923-20212937 chr2:20212921-20212935
30	FOXA1	chr2:20212317-20213341	HepG2	liver:	n/a	n/a
31	FOXA1	chr2:20212704-20213314	HepG2	liver:	n/a	n/a
32	FOXA1	chr2:20212290-20213320	HepG2	liver:	n/a	n/a
33	FOXA1	chr2:20212756-20213328	HepG2	liver:	n/a	n/a
34	FOXA1	chr2:20212375-20212683	T-47D	breast:	n/a	n/a
35	FOXA2	chr2:20212240-20212845	A549	lung:	n/a	n/a
36	FOXA2	chr2:20212757-20213227	HepG2	liver:	n/a	n/a
37	FOXA2	chr2:20212421-20212688	HepG2	liver:	n/a	n/a
38	FOXA2	chr2:20212313-20212817	A549	lung:	n/a	n/a
39	FOXP2	chr2:20212017-20212856	PFSK-1	brain:	n/a	n/a
40	GATA2	chr2:20210875-20212091	SH-SY5Y	brain:	n/a	n/a
41	GATA3	chr2:20211190-20211843	T-47D	breast:	n/a	n/a
42	GATA3	chr2:20211195-20211977	MCF-7	breast:	n/a	n/a
43	GATA3	chr2:20211602-20211908	T-47D	breast:	n/a	n/a
44	GATA3	chr2:20210645-20211957	SH-SY5Y	brain:	n/a	n/a
45	GTF2F1	chr2:20213176-20213184	H1-hESC	embryonic stem cell:	n/a	n/a
46	HA-E2F1	chr2:20211865-20212771	MCF-7	breast:	n/a	chr2:20212761-20212771 chr2:20212148-20212160
47	HDAC2	chr2:20212028-20213272	HepG2	liver:	n/a	chr2:20212924-20212938 chr2:20212921-20212935 chr2:20212926-20212940 chr2:20212917-20212931 chr2:20212920-20212934 chr2:20212925-20212939
48	HDAC2	chr2:20212339-20213087	HepG2	liver:	n/a	chr2:20212924-20212938 chr2:20212921-20212935 chr2:20212926-20212940 chr2:20212917-20212931 chr2:20212920-20212934 chr2:20212925-20212939
49	HEY1	chr2:20211853-20212959	HepG2	liver:	n/a	chr2:20211886-20211901
50	HEY1	chr2:20212323-20212964	HepG2	liver:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:20212524-20212574	SK-N-SH_RA	brain:	n/a
2	chr2:20212597-20212647	AG10803	skin:	n/a
3	chr2:20213110-20213160	SKMC	muscle:	n/a
4	chr2:20212602-20212652	HCM	heart:	n/a
5	chr2:20212597-20212647	AG09309	skin:	n/a
6	chr2:20211868-20211918	AG09319	gingival:	n/a
7	chr2:20212831-20212881	AG04449	skin:	fetal
8	chr2:20212440-20212490	GM19239	blood:	n/a
9	chr2:20212509-20212559	AG04450	lung:	fetal
10	chr2:20212600-20212650	SK-N-SH_RA	brain:	n/a
11	chr2:20212440-20212490	HEK293	kidney:	embryo
12	chr2:20213110-20213160	HMEC	breast:	n/a
13	chr2:20212501-20212551	AG10803	skin:	n/a
14	chr2:20212423-20212473	ECC-1	luminal epithelium:	n/a
15	chr2:20211868-20211918	NB4	blood:	n/a
16	chr2:20212600-20212650	AG09319	gingival:	n/a
17	chr2:20212509-20212559	HCM	heart:	n/a
18	chr2:20212600-20212650	NHDF-neo	bronchial:	n/a
19	chr2:20212509-20212559	MCF10A-Er-Src	breast:	n/a
20	chr2:20212440-20212490	HEEpiC	esophagus:	n/a
21	chr2:20211771-20211821	K562	blood:	n/a
22	chr2:20212509-20212559	ECC-1	luminal epithelium:	n/a
23	chr2:20211771-20211821	SK-N-SH_RA	brain:	n/a
24	chr2:20212440-20212490	NHDF-neo	bronchial:	n/a
25	chr2:20212501-20212551	Jurkat	blood:	n/a
26	chr2:20213110-20213160	U87	brain:	n/a
27	chr2:20212524-20212574	CMK	blood:	n/a
28	chr2:20212517-20212567	HL-60	blood:	n/a
29	chr2:20212524-20212574	HAEpiC	amniotic membrane:	n/a
30	chr2:20212597-20212647	AG04449	skin:	fetal
31	chr2:20212501-20212551	CMK	blood:	n/a
32	chr2:20211868-20211918	PrEC	prostate:	n/a
33	chr2:20212597-20212647	PANC-1	pancreas:	n/a
34	chr2:20213110-20213160	Caco-2	colon:	n/a
35	chr2:20212501-20212551	NB4	blood:	n/a
36	chr2:20211868-20211918	HIPEpiC	eye:	n/a
37	chr2:20212600-20212650	AG04450	lung:	fetal
38	chr2:20212524-20212574	HRCEpiC	kidney:	n/a
39	chr2:20212517-20212567	K562	blood:	n/a
40	chr2:20211771-20211821	HRPEpiC	eye:	n/a
41	chr2:20212600-20212650	ProgFib	skin:	n/a
42	chr2:20211868-20211918	AG04450	lung:	fetal
43	chr2:20212501-20212551	HAEpiC	amniotic membrane:	n/a
44	chr2:20212600-20212650	PFSK-1	brain:	n/a
45	chr2:20212602-20212652	HRPEpiC	eye:	n/a
46	chr2:20212524-20212574	HUVEC	blood vessel:	n/a
47	chr2:20212501-20212551	MCF10A-Er-Src	breast:	n/a
48	chr2:20212524-20212574	AG04449	skin:	fetal
49	chr2:20212423-20212473	AoSMC	blood vessel:	n/a
50	chr2:20212597-20212647	HCPEpiC	choroid plexus:	n/a

No.	Distal block	Cell Line	Cell type
1	chr2:20196234..20199275-chr2:20211073..20214096,3	MCF-7	breast:
2	chr2:20213367..20215755-chr2:20296083..20298973,4	MCF-7	breast:
3	chr2:20213361..20215470-chr2:20241959..20243915,2	MCF-7	breast:
4	chr2:20187710..20189541-chr2:20212607..20214933,2	K562	blood:
5	chr2:20208645..20229804-chr2:20247969..20254330,37	MCF-7	breast:
6	chr2:20209928..20212604-chr2:20250418..20252144,2	MCF-7	breast:
7	chr2:20188544..20190994-chr2:20211302..20213941,2	MCF-7	breast:
8	chr2:20212605..20214922-chr2:20216980..20220655,3	MCF-7	breast:
9	chr11:356190..356865-chr2:20212456..20212956,2	MCF-7	breast:
10	chr2:20100174..20102610-chr2:20210231..20211976,2	MCF-7	breast:
11	chr2:20187189..20189541-chr2:20212582..20214933,2	K562	blood:
12	chr2:20212620..20214988-chr2:20250395..20252051,2	MCF-7	breast:

Variant related genes	Relation type
MATN3	TF binding region
MATN3	CpG island
ENSG00000068697	chromatin interactions
ENSG00000118965	chromatin interactions
ENSG00000223734	chromatin interactions
ENSG00000227210	chromatin interactions
ENSG00000183891	chromatin interactions
ENSG00000132031	chromatin interactions
ENSG00000271991	chromatin interactions

Extended variants
information (count: 47 )
Associated
traits (count: 76 )

Variant overlapped rSNPs/rCNVs (count:47 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs183331787	chr2:20211712-20211713	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
2	rs557436870	chr2:20211919-20211920	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	7 gene(s)	Overlapped CNVs	n/a
3	rs577389744	chr2:20211983-20211984	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
4	rs374832651	chr2:20212072-20212073	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
5	rs104893640	chr2:20212184-20212185	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
6	rs3816644	chr2:20212206-20212207	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs556961636	chr2:20212289-20212290	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
8	rs573907581	chr2:20212331-20212332	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
9	rs541854715	chr2:20212361-20212362	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
10	rs562153429	chr2:20212431-20212432	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
11	rs188620236	chr2:20212468-20212469	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
12	rs375765000	chr2:20212474-20212475	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
13	rs8176066	chr2:20212475-20212476	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
14	rs541489709	chr2:20212522-20212523	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
15	rs564590803	chr2:20212543-20212544	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
16	rs191887902	chr2:20212601-20212602	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
17	rs62109424	chr2:20212647-20212648	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs570253007	chr2:20212667-20212668	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
19	rs192782979	chr2:20212701-20212702	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
20	rs529635220	chr2:20212702-20212703	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
21	rs183319610	chr2:20212703-20212704	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
22	rs369672778	chr2:20212732-20212733	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
23	rs373818691	chr2:20212738-20212739	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
24	rs141193443	chr2:20212820-20212821	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
25	rs73220322	chr2:20212864-20212865	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs571044170	chr2:20212928-20212929	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
27	rs62109425	chr2:20212942-20212943	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
28	rs150754964	chr2:20212957-20212958	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
29	rs573843628	chr2:20212985-20212986	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
30	rs188336790	chr2:20212997-20212998	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
31	rs552994714	chr2:20213012-20213013	Flanking Bivalent TSS/Enh Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
32	rs138268578	chr2:20213017-20213018	Flanking Bivalent TSS/Enh Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
33	rs191628136	chr2:20213025-20213026	Flanking Bivalent TSS/Enh Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
34	rs143992331	chr2:20213028-20213029	Flanking Bivalent TSS/Enh Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
35	rs578161190	chr2:20213104-20213105	Flanking Bivalent TSS/Enh Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
36	rs75297878	chr2:20213126-20213127	Flanking Bivalent TSS/Enh Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
37	rs373225393	chr2:20213165-20213166	Flanking Bivalent TSS/Enh Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
38	rs546638516	chr2:20213171-20213172	Flanking Bivalent TSS/Enh Weak transcription Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
39	rs567175560	chr2:20213208-20213209	Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
40	rs532827169	chr2:20213215-20213216	Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
41	rs549625999	chr2:20213221-20213222	Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
42	rs552821947	chr2:20213225-20213226	Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
43	rs147314519	chr2:20213255-20213256	Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
44	rs113518929	chr2:20213331-20213332	Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
45	rs528062359	chr2:20213382-20213383	Flanking Bivalent TSS/Enh Weak transcription Enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
46	rs62109426	chr2:20213439-20213440	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
47	rs73921706	chr2:20213454-20213455	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:76)

Disease	PMID	Source
Glioblastoma multiforme	21080181	CNVD
Neuroblastoma	21508638	CNVD
Breast cancer	17603634	CNVD
Cancer	16751803	CNVD
Neuroblastoma	16790693	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	17393978	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Ewing''s sarcoma	21437220	CNVD
Ependymoma	16718352	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Bladder cancer	21909424	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21785460	CNVD
Medulloblastoma	20607354	CNVD
Neuroblastoma	19638189	CNVD
Neuroblastoma	19435921	CNVD
Neuroblastoma	18574593	CNVD
Acute myeloid leukemia	18000384	CNVD
Medulloblastoma	16968546	CNVD
Medulloblastoma	22160402	CNVD
Schizophrenia	22118685	CNVD
Epilepsy	22118685	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21509527	CNVD
Leukemia	18628472	CNVD
Autism	19521722	CNVD
Autism	18522746	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	22286061	CNVD
Ovarian cancer	17908972	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Neuroblastoma	18664255	CNVD
Neuroblastoma	18765546	CNVD
Neuroblastoma	18281664	CNVD
Neuroblastoma	17289879	CNVD
Neuroblastoma	19738985	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	21364760	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD

Chromatin state (count:412 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:20200200-20211800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
2	chr2:20201800-20212400	Weak transcription	Gastric	stomach
3	chr2:20210400-20212800	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
4	chr2:20211200-20212000	Flanking Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
5	chr2:20211400-20211800	Flanking Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
6	chr2:20211400-20212000	Flanking Bivalent TSS/Enh	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
7	chr2:20211400-20212000	Flanking Active TSS	A549	lung
8	chr2:20211400-20213200	Active TSS	H9 Cell Line	embryonic stem cell
9	chr2:20211600-20211800	Bivalent/Poised TSS	H9 Derived Neuron Cultured Cells	ES cell derived
10	chr2:20211600-20211800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
11	chr2:20211600-20211800	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
12	chr2:20211600-20211800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
13	chr2:20211600-20211800	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
14	chr2:20211600-20211800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
15	chr2:20211600-20211800	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
16	chr2:20211600-20211800	Bivalent Enhancer	Brain Hippocampus Middle	brain
17	chr2:20211600-20211800	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
18	chr2:20211600-20211800	Enhancers	HUVEC	blood vessel
19	chr2:20211600-20211800	Bivalent Enhancer	NHEK	skin
20	chr2:20211600-20212000	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
21	chr2:20211600-20212000	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
22	chr2:20211600-20212000	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
23	chr2:20211600-20212000	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
24	chr2:20211600-20212000	Flanking Bivalent TSS/Enh	iPS DF 6.9 Cell Line	embryonic stem cell
25	chr2:20211600-20212000	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
26	chr2:20211600-20212000	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
27	chr2:20211600-20212000	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
28	chr2:20211600-20212000	Bivalent Enhancer	Adipose Nuclei	Adipose
29	chr2:20211600-20212000	Bivalent Enhancer	Liver	Liver
30	chr2:20211600-20212000	Bivalent/Poised TSS	Brain Dorsolateral Prefrontal Cortex	brain
31	chr2:20211600-20212000	Enhancers	Brain Substantia Nigra	brain
32	chr2:20211600-20212000	Bivalent Enhancer	Duodenum Mucosa	Duodenum
33	chr2:20211600-20212000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
34	chr2:20211600-20212000	Enhancers	Ovary	ovary
35	chr2:20211600-20212000	Bivalent/Poised TSS	Hela-S3	cervix
36	chr2:20211600-20212000	Flanking Bivalent TSS/Enh	HepG2	liver
37	chr2:20211600-20212200	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
38	chr2:20211600-20212200	Bivalent Enhancer	Primary T helper naive cells from peripheral blood	blood
39	chr2:20211600-20212200	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
40	chr2:20211600-20212200	Flanking Bivalent TSS/Enh	Brain Anterior Caudate	brain
41	chr2:20211600-20212400	Bivalent Enhancer	Brain Angular Gyrus	brain
42	chr2:20211600-20212800	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
43	chr2:20211600-20212800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
44	chr2:20211600-20213000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
45	chr2:20211600-20213000	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
46	chr2:20211800-20212000	Bivalent Enhancer	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
47	chr2:20211800-20212000	Flanking Bivalent TSS/Enh	H9 Derived Neuron Cultured Cells	ES cell derived
48	chr2:20211800-20212000	Flanking Bivalent TSS/Enh	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
49	chr2:20211800-20212000	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
50	chr2:20211800-20212000	Flanking Bivalent TSS/Enh	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links